$19.37
0.663.53%
Pre-Market: 9:26 AM EDT
Comments
Loading...
Cadrenal Therapeutics Stock Guidance | NASDAQ:CVKD | Benzinga
Cadrenal Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadrenal Therapeutics Inc (CVKD) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Cadrenal Therapeutics (CVKD)?
There have been no specific sales or earnings guidance reported for Cadrenal Therapeutics in recent months.
Browse guidance and forecast on all stocks.